Key result
Editorial reviews contemporary strategies and clinical considerations for cardiovascular risk assessment.
CVD risk scoring aids postmenopausal HT decisions beyond age or menopause timing; leaves open whether it improves outcomes in practice.
Department of Medicine, University of California, San Diego, School of Medicine, La Jolla, CA. Address correspondence to: Cynthia A. Stuenkel, MD, University of California, San Diego, 9500 Gilman Drive, MC 0659, La Jolla, CA 92093-0659. E-mail: [email protected] Received 26 March, 2021 Revised 26 March, 2021 Accepted 26 March, 2021 Funding/support: None reported. Financial disclosure/conflicts of interest: C.A.S. has received funding from ICON Clinical Research LLC. Data and Safety Monitoring Board, Mithra Pharmaceuticals.
No takes yet. Share an insight, caveat, or question.
Cynthia A. Stuenkel (2021) conducted an editorial in Cardiovascular risk. This editorial discusses cardiovascular risk assessment without presenting primary quantitative clinical data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: